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Neuronal and Glial Glycine Transporters
Have Different Stoichiometries
et al., 1998) and hippocampus (Bergeron et al., 1998). In
principle, this should allow potentiation of NMDARs by
sudden increases of extracellular glycine. Such rises
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may come from glycine spillover from nearby glycinergicCentre National de la Recherche Scientifique
terminals (Fern et al., 1996). Another possible origin isEÂ cole Normale SupeÂ rieure
reverse uptake, whereby transporters become a cal-46 rue d'Ulm
cium-independent source of glycine. Because of the75230 Paris cedex 05
reduction of Na1 and Cl2 electrochemical gradients dur-France
ing ischemic conditions, reverse transport may also be
the cause of the massive liberation of glycine, which
has been observed (Baker et al., 1991).Summary
Many glycine transporters have been cloned in the
CNS of mammals. All are members of the Na1/Cl2-cou-A neurotransmitter transporter can potentially medi-
pled symport family and derive from two genes, GlyT1ate uptake or release of substrate, and its stoichiome-
and GlyT2. The three GlyT1 isoforms (GlyT1a±GlyT1c)try is a key factor that controls the driving force and
differ only in their short N termini. The GlyT2 isoformsthus the neurotransmitter flux direction. We have used
(GlyT2a±GlyT2b) have an additional z200 amino acida combination of electrophysiology and radio-tracing
long N terminus and a 48% identity with GlyT1 in theirtechniques to evaluate the stoichiometries of two gly-
overlapping sequences (reviewed by Palacin et al.,cine transporters involved in glycinergic or glutamater-
1998).gic transmission. We show that GlyT2a, a transporter
The cellular and tissue localizations of the variouspresent in glycinergic boutons, has a stoichiometry
GlyT subtypes appear to be finely regulated (Borowskyof 3 Na1/Cl2/glycine, which predicts effective glycine
and Hoffman, 1998). In spinal cord, brainstem, and cere-accumulation in all physiological conditions. GlyT1b,
bellum, GlyT2 has been found to be a reliable markera glial transporter, has a stoichiometry of 2 Na1/Cl2/
of glycinergic neurons both by in situ hybridization (Ad-glycine, which predicts that glycine can be exported
ams et al., 1995; Luque et al., 1995; Zafra et al., 1995b)or imported, depending on physiological conditions.
and immunocytochemistry studies (Jursky and Nelson,GlyT1b may thus modulate glutamatergic synapses
1995; Zafra et al., 1995a; Spike et al., 1997). GlyT2 isby increasing or decreasing the glycine concentration
detected in all glycinergic boutons, but outside the ac-around N-methyl-D-aspartate receptors (NMDARs).
tive zones (Spike et al., 1997). In contrast, GlyT1 is lo-
cated in fine astroglial processes both around gly-
cinergic terminals (Zafra et al., 1995a) and in areasIntroduction
devoid of strychnine-sensitive receptors (Smith et al.,
1992; Zafra et al., 1995a).The glycine transporters identified in the CNS are likely
In the present paper, we investigate the stoichiometryto play roles both at inhibitory glycinergic synapses,
and kinetic properties of GlyT1b and GlyT2a to under-where glycine activates low-affinity, strychnine-sensi-
stand how these two transporters achieve their specifictive, chloride-permeable receptors (GlyRs) (Aprison and
functions in neurons and glia. ImmunocytochemistryWerman, 1965; Grenningloh et al., 1987) and at gluta-
studies have shown that glycinergic neurons, both inmatergic synapses (Ascher, 1990; Attwell et al., 1993),
situ (Storm-Mathisen and Ottersen, 1990) and in culture
where glycine plays a facilitatory role as a high-affinity
(Poyatos et al., 1997), have a higher glycine content
coagonist with glutamate of N-methyl-D-aspartate re-
than do glial cells. This difference is also observed in
ceptors (NMDARs) (Johnson and Ascher, 1987; see re- transfected cells expressing either GlyT1 or GlyT2 (Poy-
view in Danysz and Parsons, 1998). In brainstem and atos et al., 1997). A high level of glycine in glycinergic
spinal cord, glycine uptake does not influence the time terminals actually appears to be a requirement for effec-
course of inhibitory postsynaptic currents (Titmus et tive filling of the synaptic vesicles because of the low
al., 1996; Singer and Berger, 1999), and the function of affinity of the vesicular inhibitory amino acid transporter
glycine transporters is to ensure a rapid resupply of (VIAAT) (Sagne et al., 1997).
presynaptic terminals (Zafra et al., 1997) and perhaps To date, conclusive stoichiometries have been estab-
to limit intersynaptic spillover (see review in Bergles et lished under voltage-clamp conditions for only a few
al., 1999). In excitatory transmission, the capacity of transporters, such as the glutamate transporters EAAT3
glycine transporters to keep the local extracellular gly- (Zerangue and Kavanaugh, 1996) and GLT-1 (Levy et
cine concentration ([Gly]o) below saturating levels for al., 1998), and the epithelial Na1/glucose transporter
NMDARs has been demonstrated in a few cases, such SGLT1 (Mackenzie et al., 1998). Based on earlier work on
as in a model system in which glycine transporters and reconstituted vesicles with GABA transporters (Radian
NMDARs were coexpressed in Xenopus oocytes (Supplis- and Kanner, 1983), it is generally assumed that most
son and Bergman, 1997) and in slices of brainstem (Berger Na1/Cl2-coupled transporters have a stoichiometry of
2 Na1/Cl2 per substrate molecule (see reviews in Kanner
and Schuldiner, 1987; Palacin et al., 1998). In the present* To whom correspondence should be addressed (e-mail: supplis@
wotan.ens.fr). study, we show that this prediction is correct for GlyT1b
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but that the neuronal GlyT2a transports an additional
Na1 ion. We also show that GlyT2a reverse transport is
limited compared with that of GlyT1b. These two differ-
ences indicate that GlyT1b has the properties expected
for a transporter controlling the extracellular glycine
concentration and thus tonically modulating NMDARs,
whereas GlyT2a appears adapted to accumulate glycine
into presynaptic terminals.
Results
GlyT1b and GlyT2a Have a Different
Charge/Glycine Ratio
In voltage-clamped Xenopus oocytes expressing either
GlyT1b (Figure 1A) or GlyT2a (Figure 1B), glycine (25 mM)
evokes a maintained inward current (IT), which requires
both Na1 and Cl2 ions. To measure the net number of
charges translocated with each glycine molecule (zT),
we compared the time integral of the glycine-induced
current (QT) with the simultaneous 14C glycine uptake
(JGly). Like the current induced by glycine, the radioactive
flux required both Na1 and Cl2.
When 14C glycine uptake was measured in the pres-
ence of Na1 and Cl2 and plotted as a function of QT, a
striking difference was observed between the two trans-
porters. Figure 1C shows the linear relationship between
QT (shaded in Figures 1A and 1B) and the corresponding
glycine uptake for various expression levels in GlyT1b1
Figure 1. Charge Coupling of GlyT1b and GlyT2aor GlyT2a1 oocytes, for holding potentials ranging from
Comparison of U-14C glycine (A±C) or 36Cl (D) uptake with the time2120 to 0 mV. The slope
integral of the glycine-evoked currents recorded under voltage-
clamp.zT 5
QT
F JGly
,
(A and B) Current response evoked by 25 mM 14C glycine (closed
bar) in control Ringer solution or when Na1 or Cl2 was replaced by
choline or gluconate, respectively. Holding potential was 280 mV.where F is the Faraday constant, is 1.01 6 0.04 elemen-
In Na1-free solution, application of 25 mM U-14C glycine during 1 totary charge (e0)/glycine (n 5 20) for GlyT1b and 2.14 6 2 min produced the same uptake in GlyT1b1 oocytes (0.51 6 0.19
0.17 e0/glycine (n 5 20) for GlyT2a. The charge/glycine pmol, n 5 3) as in noninjected oocytes (0.56 6 0.36 pmol, n 5 4).
ratio was voltage independent between 2120 and 0 mV Similar ªbaselineº values were observed in Cl2-free solutions for
GlyT1b (0.55 6 0.15 pmol, n 5 3), but they were slightly higher forfor GlyT1b, but for GlyT2a, zT increased slightly with
GlyT2a (1.53 6 0.7 pmol, n 5 3).hyperpolarization, from 1.9 e0 at 0 mV to 2.3 e0 at
(C) Time integrals of glycine-evoked currents (shaded in [A] and [B]),2120 mV.
expressed in pmol of elementary charges, plotted as a function of
A net charge of 11 per glycine for GlyT1b is in perfect glycine uptake for GlyT1b1 [n 5 19] and GlyT2a1 [n 5 18]) oocytes
agreement with the stoichiometry of 2 Na1/Cl2/glycine at various potentials. Glycine applications varied between 45 and
determined for native transporters in reconstituted 120 s.
(D) 36Cl uptake is plotted as a function of the equivalent glycinemembrane vesicles (Zafra and Gimenez, 1986; Aragon
uptake, estimated from the time integrals of glycine-evoked currentset al., 1987). In contrast, a net charge per glycine of 12
(shaded in [A] and [B]), using their specific charge-to-glycine fluxfor GlyT2a could be explained by one of the following
ratios. GlyT1b1 (n 5 8) and GlyT2a1 (n 5 17) oocytes were preequili-
mechanisms: an uncoupled conductance activated by brated in a solution containing 90 mM Na-gluconate and 10 mM
glycine, the cotransport of three Na1 ions, or a zero net NaCl before application of 500 mM glycine in a Ringer solution con-
taining 10 mM Na 36Cl and 90 mM Na-gluconate. The holding poten-flux for Cl2 (assuming that no ions other than Na1 and
tial was 230 mV.Cl2 are involved). To rule out the last hypothesis, we
simultaneously measured Cl2 uptake and QT. To mini-
mize the Cl2 fluxes not linked to glycine uptake, oocytes
Uptake Current as a Functionwere held at 230 mV, close to ECl. QT was proportional
of Membrane Potentialto 36Cl2 uptake, with ratios of 0.93 6 0.06 e0/Cl2 (n 5 8)
In control solution, voltage jumps revealed slow tran-and 2.07 6 0.04 e0/Cl2 (n 5 17) for GlyT1b and GlyT2a,
sient currents in both GlyT1b1 (Figure 2A) and GlyT2a1respectively. Using the previously determined values of
(Figure 2E) oocytes that were absent in noninjected oo-zT, these results lead to identical ratios of 1.05 and 1.03
cytes. These transients disappeared when saturatingCl2 per glycine for the two transporters (Figure 1D). To
glycine concentrations were applied (Figures 2B andinvestigate further the origin of this difference in charge/
2F). Thus, as for other Na1-coupled transporters, tran-glycine ratios, we analyzed some of the kinetic proper-
ties of both transporters. sient currents are negatively coupled to steady-state
Glycine Transporters' Stoichiometries
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Figure 2. Relaxation and Uptake Currents of GlyT1b and GlyT2a
(A and B) A representative GlyT1b1 oocyte was held at 240 mV, and the potential was stepped to values ranging from 140 mV to 2160 mV
(20 mV decrements), in the absence (A) or presence (B) of 200 mM glycine.
(C) I±V relationships of the steady-state currents recorded in (A) and (B) (see corresponding symbols).
(D) I±V relationship of the glycine-evoked current.
(E and F) A representative GlyT2a1 oocyte was held at 240 mV, and the potential was stepped to values ranging from 140 mV to 2140 mV
(20 mV decrements), in the absence (E) or presence (F) of 1 mM glycine.
(G) I±V relationships of the steady-state currents recorded in (A) and (B) (see corresponding symbols).
(H) I±V relationship of the steady-state glycine-evoked current.
In (A) and (B), and (E) and (F), the dashed line indicates the zero current level, and the first 1.75 ms after each voltage jump was omitted for
clarity. In (D) and (H), the conductance corresponds to the linear regression of the current values between 2110 and 270 mV (dashed line).
uptake currents (Loo et al., 1993; Mager et al., 1993). respectively). At potentials more positive than 250 mV,
KGly0.5 increased with the membrane potential. The voltageThey will be analyzed in detail in a subsequent paper.
Applications of glycine at high concentrations (200 dependence was steeper for GlyT2a than for GlyT1b,
with equivalent charges of 0.78 6 0.03 e0 (n 5 6) and 1.38 6mM to 1 mM) induced inward currents at all potentials
tested (Figures 2B and 2F). The transport currents, IT, 0.07 e0 (n 5 12) for GlyT1b and GlyT2a, respectively.
were isolated by subtraction of the steady-state currents
recorded in the absence of glycine (Figure 2F, diamonds)
from those recorded in its presence (Figure 2F, circles). GlyT2a Has a Higher Hill Coefficient for Na1
than Does GlyT1bThe IT±voltage relationships were quasiohmic for both
transporters (Figures 2D and 2H), but GlyT1b IT displayed Uptake currents of GlyT1b and GlyT2a were recorded
as a function of [Na1]o and membrane potential using aa small inward rectification at positive potentials. No
current inversion was observed for either transporter. saturating (1 mM) glycine concentration (Figures 3D and
3E). In these experiments, choline was substituted for
Na1 to maintain a constant monovalent cation concen-GlyT1b and GlyT2a Have Similar Apparent
Glycine Affinities tration. When Na1 was completely replaced by choline,
no transporter-mediated glycine uptake was observed,The uptake currents of GlyT1b and GlyT2a, evoked by
rapid superfusion of glycine at various concentrations, and the transporter-specific transient currents observed
in the absence of glycine but in the presence of Na1were recorded at different potentials using the voltage-
step protocol described in Figures 2A and 2B (Figures (Figures 2A and 2E) also disappeared, suggesting that
choline does not interact with the transporters.3A and 3B). To limit the depletion of juxtamembrane
glycine at low concentrations (see Supplisson and Berg- At 2130 mV, the KNa0.5 of GlyT1b was 5.9 6 0.5 mM (n 5
5), about half that of GlyT2a (10.2 6 0.2 mM, n 5 4)man, 1997), only oocytes with low expression levels
(jITmaxj , 200 nA and 400 nA at Vm 5 240 mV for GlyT1b (Figure 3F). The KNa0.5 of GlyT2a increased steeply with
voltage. The voltage dependence of the KNa0.5 was de-and GlyT2a, respectively) were considered. In these con-
ditions, the dose±response curves could be fitted using scribed by equivalent charges of 0.25 6 0.04 e0 (n 5
5) and 0.56 6 0.04 e0 (n 5 4) for GlyT1b and GlyT2a,a Michaelis-Menten equation at all potentials.
The glycine concentrations producing half-maximal respectively.
The Na1 Hill coefficient of GlyT1b had a mean valueresponses (KGly0.5) were voltage independent at potentials
more negative than 250 mV (Figure 3C) and had similar of 1.41 6 0.02 (n 5 5). In contrast, the Hill coefficient of
GlyT2a was consistently close to or higher than 2 (2.21 6values for the two transporters (22.6 6 2.5 mM [n 5 6]
and 24.6 6 2.3 mM [n 5 12] for GlyT1b and GlyT2a, 0.05, n 5 4 from 2130 to 0 mV, p , 0.001) (Figure 3G).
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Figure 4. Microionjection of Na1 and Glycine Evoked Outward Cur-
rents in GlyT1b1 and GlyT2a1 Oocytes
(A and B) Current traces showing the activation of outward currents
and/or diminution of inward glycine-evoked current after intracellu-
lar injection (vertical bars, indicated by arrows) of 16 nmol of glycineFigure 3. Apparent Affinities of Glycine Transporters for Na1 and
for GlyT1b (A) and GlyT2a ([B], top trace) or glycine and NaCl forGlycine
GlyT2a ([B], bottom trace). Glycine (100 mM, closed bar) was super-Glycine-evoked currents of GlyT1b and GlyT2a were measured as
fused before and after intracellular injection. Application of 10 mMdescribed in Figure 2 for various [Gly]o or [Na1]o. Amplitudes smaller
of the GlyT1 inhibitor ORG24598 (A) or 5 mM of the GlyT2 inhibitorthan 5 nA were discarded.
ORG26176 ([B], shaded bar) blocked both inward and outward trans-(A and B) Dose±response curves for glycine concentrations between
porter currents (VH 5 240 mV). The dashed line represents the2 mM and 3 mM (GlyT1b, [A]) or between 1 mM and 2 mM (GlyT2a,
current level in the presence of inhibitor.[B]), for membrane potentials between 150 mV and 2130 mV. Solid
(C) Diagram of the experimental protocol. The oocytes were impaledlines represent fits to the data using a Michaelis-Menten equation:
with a third pipette connected to a nanoliter injector (WPI) and filled
with a concentrated (1 M) solution of either glycine or glycine andIGlyTG 5 IGlyTG max/{1 1 KGly0.5/[Gly]}.
NaCl. The estimated increase in [Gly]i, [Na1]i, and [Cl2]i for a maximal
(C) Voltage dependence of the apparent glycine affinity KGly0.5. Solid 16 nl injection is z30 mM, modeling the oocyte as a 1 mm diameter
lines are fits to the data using the phenomenological equation sphere.
KGly0.5 5 A 1 Be(2zdGlyVmF/RT).
(D and E) Dose±response curves for Na1 concentrations between
ET 5
2.3 R T
(nNa 2 nCl)F
log1[Na
1]nNao [Cl2]nClo [Gly]o
[Na1]nNai [Cl2]nCli [Gly]i
2 (1)1 and 100 mM (GlyT1b, [D]) or between 2 and 100 mM (GlyT2a, [E])
for membrane potentials between 130 mV and 2130 mV. Solid lines
represent fits to the data using a Hill equation: where R, T, and F have their usual meanings, and nNa
and nCl indicate, respectively, the number of Na1 and Cl2INaTG 5 INaTGmax/{1 1 (KNa0.5/[Na1])nNa}.
ions coupled to the transport of each glycine molecule.
Values over 120 mV were not fitted. Decreasing the driving force is necessary to allow
(F) Voltage dependence of the apparent Na1 affinity KNa0.5. Solid lines measurement of the transport equilibrium potential, ET,are fit to the data using the phenomenological equation
in a practical voltage range. Because outward current
KNa0.5 5 A 1 B e(2zdNaVmF/RT). could not be detected with GlyT2a in experiments using
low [Na1]o or low [Cl2]o, we chose to manipulate the(G) Hill coefficients (nNa), as determined in (D) and (E). The dashed
intracellular concentrations. In the following experi-line corresponds to nNa 5 2.
ments, voltage-clamped GlyT1b1 or GlyT2a1 oocytes
were impaled with a nanoliter injector micropipette, andThe Difference in Stoichiometry Is Confirmed
controlled volumes (4 to 16 nl) of solutions containingby the Determination of the Reversal
either glycine (1 M) alone or glycine (1 M) and NaCl (1 M)Potential as a Function of [Na1]o and [Gly]o
were injected prior to recording IT as a function of eitherThe fact that the Hill coefficients estimated from the Na1
[Na1]o, [Cl2]o, or [Gly]o (Figure 4C). For subtraction ofactivation curves were ,2 for GlyT1b but .2 for GlyT2a,
the oocytes' background current, we used two spe-together with the difference in charge/glycine ratios,
cific glycine uptake inhibitors of GlyT1b and GlyT2asuggested that GlyT2a cotransports a higher number of
(ORG24598 and ORG26176, respectively) (G. Walker etNa1 ions. To address directly this question, we set out
al., 1999, Soc. Neurosci., abstract) that blocked all in-to measure the equilibrium potentials of GlyT1b and
ward and outward glycine-evoked current (Figures 4AGlyT2a and the changes produced by alterations of
and 4B). The mean glycine-evoked current inhibitions[Na1]o, [Cl2]o, and [Gly]o.
([Gly]o 5 200 mM, VH 5 240 mV) with 5 mM ORG24598The equilibrium potential of a glycine transporter de-
and ORG26176 were 100.1% 6 0.5% (n 5 4) andpends on the ionic and substrate electrochemical gradi-
ents, as indicated by the thermodynamic relationship: 101.6% 6 1.8% (n 5 4), respectively. These percentages
Glycine Transporters' Stoichiometries
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of inhibition confirm the absence of uncoupled currents predictions of 118 mV and 87 mV for 2 Na1/1Cl2/1 gly-
cine and 3 Na1/1Cl2/1 glycine, respectively. The differ-over the range of measured ERev, as found also in substi-
tution experiments in which Na1 or Cl2 was replaced ence in nNa confirms that the additional charge of GlyT2a
is carried by a third Na1 ion coupled to glycine uptake.by choline or gluconate. In this condition, it is reasonable
to assume that the current reversal potential, ERev, corre-
sponds to the transport equilibrium potential, ET. Neuronal and Glial Glycine Transporters Have
Microinjections of glycine (4 to 16 nl) were sufficient Different Reverse Transport Kinetics
to evoke large outward currents in GlyT1b1 oocytes at The inward rectification of GlyT2a IT±Vm (Figure 5B) com-
VH 5 240 mV (Figure 4A, middle trace). In contrast, pared with the linear GlyT1b IT±Vm (Figure 5A) observed
outward currents were never detected after injection of at low external Na1 suggested that the two transporters
glycine alone in GlyT2a1 oocytes (Figure 4A, bottom may have different reverse transport characteristics.
trace), though the injection produced a marked de- This was confirmed in experiments in which transient
crease of the inward uptake current, indicating the re- intracellular accumulations of glycine were induced by
duction of the driving force for influx. It was only when superfusion of the oocytes under voltage clamp with a
glycine and NaCl were coinjected that outward currents saturating glycine concentration for 1 to 3 min (Figures
were evoked in GlyT2a1 oocytes (Figure 4B, bottom 6A±6C). The steady-state currents of GlyT1b1 and
trace). Following such combined injection, a transient GlyT2a1 oocytes recorded in absence of glycine prior
inward current was always observed in either nonin- to (I1) and after (I2) glycine application (1 mM) were plot-
jected oocytes or GlyT1b1 or GlyT2a1 oocytes, indicat- ted as a function of time (Figure 6A). With GlyT1b1 oo-
ing that this transient current is unrelated to glycine cytes, glycine accumulation (0.29 6 0.05 nmol, n 5 15)
transporter expression (Figure 4B). Once the transient evoked a net outward current (I2 2 I1) upon glycine re-
current had subsided, steady outward currents were moval, which increased exponentially with depolariza-
observed at VH 5 240 mV for both transporters, sug- tion, as shown in the current±voltage (I±V) relationship
gesting that the intracellular concentrations of glycine, of Figure 6B. These outward currents were blocked by
Na1, and Cl2 did not change significantly during the time ORG24958 (data not shown), and their amplitudes in-
of the experiment (9 to 15 min postinjection). Oocytes in creased with glycine uptake (Figure 6C). The presence
which the injection produced a nonspecific increase in of a large scatter in Figure 6C suggested that variation
currents at all potentials were not considered. in the basal intracellular Na1, Cl2, or glycine concentra-
A direct evaluation of stoichiometry was obtained by tions of individual oocytes may alter the efflux rate. In
studying ERev changes as a function of the external con- contrast, similar glycine accumulations in GlyT2a1 oo-
centration of a given transported ligand ([X]o). With all cytes (0.25 6 0.03 nmol, n 5 11) did not evoke an out-
other factors being constant, equation (1) can be simpli- ward current at any of the potentials tested (Figures 6A,
fied to ET 5 aX log([X]o) 1 bX, where the slope aX 5 2.3 left panel, and 6B), even when Na1 was replaced by Li1
R T nX/(zT F) depends on zT and nX, the stoichiometry of (data not shown).
the coupled variable (Zerangue and Kavanaugh, 1996). These experiments demonstrate that following a com-
Thus, for a 10-fold change in external glycine concentra- parable glycine load (Figure 6C), glycine is exported at
tion, the predicted changes in ET at 238C are 58 and 29 a significant rate from GlyT1b1 oocytes but not from
mV for zT 5 1 and zT 5 2, respectively. These values GlyT2a1. This suggests either that the GlyT2a apparent
agree with the changes in ERev between 10 and 100 mM affinities for intracellular Na1, Cl2, or glycine are much
glycine that were of 61.0 6 4.2 mV (n 5 7) and 28.2 6 lower than those of GlyT1b or that the forward and back-
1.8 mV (n 5 12) for GlyT1b (injection of 16 nmol of ward transport cycles do not have the same rate-limiting
glycine) and GlyT2a (injection of 16 nmol of NaCl 1 step. Such transient release could be of physiological
glycine), respectively. The GlyT1b/GlyT2a slope ratio is relevance because following synaptic release of glycine
2.16, close to the value of 2.12 calculated from the exper- and its reuptake in neuron and glial cells, reverse trans-
imental charge/glycine ratio. This result confirms that port by GlyT1b may occur if the extracellular concentra-
the additional charge of GlyT2a is thermodynamically tion is driven too low by GlyT2 (Figure 7A).
coupled to transport. As expected, the ERev slopes deter- To investigate the change in transport kinetics pro-
mined for different [Cl2]o (100, 33, and 10 mM) were duced by glycine accumulation, oocytes were exposed
58.6 6 6.1 mV (n 5 7) and 36.3 6 0.9 mV (n 5 8) for continuously to a saturating glycine concentration
GlyT1b and GlyT2a, respectively. This gives nCl 5 1.0 (1 mM) for periods of up to 60 min, while the glycine-
for GlyT1b and nCl 5 1.2 for GlyT2a, confirming that 1 evoked current was monitored at different potentials
Cl2 is transported per glycine molecule, as determined every 40 s. The leak current measured before the appli-
previously with flux experiments (Figure 1D). cation of glycine was subtracted from the total current.
To determine the Na1 coupling, we recorded the IT ±Vm The evolution of IT during and following a 1 hr glycine
relationships for four Na1 concentrations in the pres- application (Figure 6D, closed bar) from two representa-
ence of 100 mM glycine. Results of representative exper- tive experiments with GlyT1b1 and GlyT2a1 oocytes is
iments with GlyT1b1 and GlyT2a1 oocytes are shown plotted in Figure 6D. For GlyT1b1 oocytes, uptake cur-
Figures 5A and 5B, respectively. For GlyT1b, the slope rents recorded at VH 5 240 mV (Figure 6D, continuous
of ET 5 f(log[Na1]o was aNa 5 114.7 6 8.1 mV (n 5 10) line) fell dramatically as the glycine application was pro-
per 10-fold Na1 concentration change, which, as zT 5 longed, approaching zero after 1 hr, suggesting that the
1, gave a number of Na1 ions per glycine of nNa 5 2.0 6 transporter was close to equilibrium. In five experiments,
0.1 (Figure 5C). For GlyT2a, the slope was aNa 5 91.6 6 a 50% reduction of IT was observed after 6.2 6 0.45 min
4.6 mV (n 5 8), giving nNa 5 3.1 6 0.1, considering zT 5 of glycine superfusion. As shown in the IT ±Vms of Figure
6E, the decrease in inward current did not result from2 (Figure 5D). The slopes are close to the theoretical
Neuron
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Figure 5. Na1 Dependence of Transport Reversal Potential Confirms the Difference in Stoichiometry between GlyT1b and GlyT2a
(A and B) GlyT1b1 oocytes were injected with 16 nmol of glycine (A), while GlyT2a1 oocytes were injected with 16 nmol of glycine and NaCl
(B). Following injection, oocytes were superfused with 100 mM glycine solutions containing different Na1 concentrations (choline substitution).
Transport currents were isolated from leak currents by subtraction of the currents measured in the presence of 10 mM of the transporter
inhibitor ORG24598 for GlyT1b (A) or 5 mM of the transporter inhibitor ORG26176 for GlyT2a (B).
(C and D) GlyT1b (C) and GlyT2a (D) reversal potentials are plotted as a function of the external Na1 concentration after injection of 16 nmol
of glycine (GlyT1b, n 5 10) or glycine and NaCl (GlyT2a, n 5 7). The solid line is a fit of the data with a logarithmic equation.
a change in the chord conductance but rather from a were similar with 2.9 6 0.45 (n 5 2, GlyT1b) and 2.4 6 0.1
(n 5 5, GlyT2a) nmol after 30 min of glycine incubation,shift of the reversal potential toward more negative val-
ues. Upon removal of glycine, a larger driving force for despite the fact that in these experiments, the apparent
expression level of GlyT2a was only a quarter of that ofreverse transport was present, which produced an out-
ward current that decreased progressively. In contrast, GlyT1b (as indicated by their uptake currents of 445 and
202 nA for GlyT1b and GlyT2a, respectively).prolonged application of glycine on GlyT2a1 oocytes
did not produce a similar decrease of the inward current
at negative potentials, indicating that the uptake capac- Discussion
ity of GlyT2a was maintained (Figure 6D). At 140 mV, IT
became outward after z15 min of glycine superfusion, Despite their involvement in both inhibitory and excit-
atory transmission, the kinetics and energetics of gly-allowing determination of the GlyT2a reversal potential.
The IT ±Vms recorded at different times (Figure 6E) showed cine transporters have not been characterized to the
same extent as other neurotransmitter transporters.an increasing outward rectification, with a progressive
shift of ERev toward less positive values. Here, we report that the neuronal and glial glycine trans-
porters have different stoichiometries and reverse trans-In Figure 6F, GlyT1b and GlyT2a reversal potentials
were plotted as a function of glycine uptake, estimated port capabilities. These differences correlate well with
the hypothesis of specialized tasks for both transport-from the time integral of IT. The mean values of ERev for
2 nmol of glycine uptake were 114.1 6 7.9 mV (n 5 12) ers, suggested by their mRNA and protein localization
(Smith et al., 1992; Liu et al., 1993; Zafra et al., 1995a,for GlyT1b and 137.1 6 1.6 mV (n 5 9) for GlyT2a,
indicating that GlyT2a was less sensitive to glycine ac- 1995b): fast reuptake of glycine into the presynaptic
terminals for GlyT2a and control of the extracellular gly-cumulation, as expected for a higher stoichiometry. The
glycine uptakes calculated from the time integral of IT cine concentration for GlyT1b.
Glycine Transporters' Stoichiometries
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Figure 6. Difference in Outward Current following Glycine Uptake
(A) GlyT1b (open circles) and GlyT2a (closed circles) steady-state currents were monitored every 30 s before and after a 1 min application of
1 mM glycine (closed bar) using voltage-step protocols, as in Figure 2. Values for potentials between 270 mV and 130 mV are plotted as a
function of time (VH 5 240 mV).
(B) Difference (I2 2 I1) in the steady-state current amplitudes before (I1) and just after (I2) a 2.6 min application of 1 mM glycine (n 5 15 and
n 5 8 for GlyT1b [open circles] and GlyT2a [closed circles], respectively). The solid line corresponds to a fit to I 5 Io e(2zdVmF/RT) with zd 5 0.52 6
0.05 (n 5 15, SD).
(C) Relationship between glycine uptake (estimated from the time integral of the glycine-evoked current) and the current difference (I2 2 I1)
for GlyT1b (open circles) and GlyT2a (closed circles). Solid lines are linear regression fits to the data. Two values obtained from GlyT1b1
oocytes for which the leak increased during the experiment are also plotted (open diamonds).
(D) GlyT1b (top) and GlyT2a (bottom) steady-state currents were monitored every 40 s using voltage-step protocols, as above, prior to, during,
and after a 1 hr application of 1 mM glycine (closed bar). During this experiment, the oocyte was held 91% of the time at 240 mV. Evolution
of the current is shown for potentials of 2100 mV (shaded circles), 240 mV (solid line), and 140 mV (open circles).
(E) I±V relationship of GlyT1b (top, open symbols) and GlyT2a (bottom, closed symbols) for different 1 mM glycine application durations: 5 s
(open squares, closed squares), 5 min (open circles, closed circles), 10 min (open triangles, closed triangles), 20 min (open diamonds, closed
diamonds), 30 min (open upside-down triangles, closed upside-down triangles), and 40 min, 50 min, and 60 min (solid lines).
(F) Evolution of the reversal potential as a function of the glycine uptake for the same oocytes as in (D) and (E), estimated from the time
integrals of the glycine-evoked currents (GlyT1b, open circles; GlyT2a, closed circles). Mean values of ERev for 2 nmol glycine uptake and
mean values of glycine uptake for ERev 5 120 mV are indicated (n 5 12 and n 5 9 for GlyT1b [open diamonds] and GlyT2a [closed diamonds],
respectively).
GlyT1b and GlyT2a Have Different [Gly]i, and [Na1]o: (1) the transport reversal potentials
were shifted by 61 mV for GlyT1b and 28.6 mV for GlyT2aNa1 Stoichiometries
Simultaneous measurements of glycine-evoked current for a 10-fold change in [Gly]o, as expected from their
difference in charge/glycine ratio; (2) the limited de-and glycine uptake reveal a major difference between
the charge transferred per glycine of the neuronal and crease of GlyT2a ERev observed during prolonged appli-
cations of glycine, compared with the large shift ofglial GlyTs. For GlyT1b, the charge-to-substrate flux ra-
tio of 11 found between 2120 and 0 mV matches, that GlyT1b ERev, is consistent with a lower sensitivity of ET
to a change in [Gly]i; (3) the variations of ERev for GlyT1bwhich is expected from the ªclassicº 2 Na1/Cl2/glycine
stoichiometry (Zafra and Gimenez, 1986; Aragon et al., and GlyT2a as a function of [Na1]o agree with the predic-
tions for nNa 5 2 and nNa 5 3, respectively. Thus, we1987). In contrast, the excess charge found for GlyT2a
(zT < 12) is not compatible with this stoichiometry. The confirm that the classic stoichiometry of 2 Na1/Cl2/gly-
cine is correct for GlyT1b but conclude that for GlyT2a,additional charge does not result from an absence of
net Cl2 cotransport by GlyT2a, since both transporters the stoichiometry is 3 Na1/Cl2/glycine.
In the Na1/Cl2-coupled transporter family, the numberhave equal glycine and Cl2 fluxes, and [Cl2]o affects the
transporters' reversal potentials. The fact that the extra of Na1 ions energetically coupled to the uptake of neuro-
transmitters appears to be variable, in contrast to thecharge is carried by a third Na1 ion thermodynamically
coupled to glycine uptake is further supported by three invariance of the Cl2 coupling (nCl 5 1) (Rudnick, 1998).
The lowest coupling (nNa 5 1) has been proposed forsets of observations of the ERev dependence of [Gly]o,
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Figure 7. Complementary Roles of Glycine Transporters
(A) GlyT1b (thin line) and GlyT2a (thick line) equilibrium potentials as a function of the external glycine concentration, assuming [Na1]o5 145
mM, [Na1]i 5 14 mM, [Cl2]o 5 120 mM, [Cl2]i 5 6 mM, 378C, and glial and neuronal intracellular glycine concentrations of 2 mM and 10 mM,
respectively. Reverse transport conditions are shaded. For a resting potential of 270 mV (y axis), GlyT1b is close to equilibrium for [Gly]o 5
100 nM, while the driving force for uptake by GlyT2a is still 50 mV at this external concentration, which could lead to a kinetic advantage of
GlyT2a over GlyT1b.
(B) At glycinergic synapses (left), glycine is removed from the extracellular space by complementary activity of the neuronal GlyT2a and GlyT1b
found on the neighboring astrocyte processes. If, due to GlyT2a activity, [Gly]o falls below the GlyT1b equilibrium value, these transporters
will then work backward, letting glycine leak out from astrocytes to be subsequently pumped back into neurons by GlyT2a. At glutamatergic
synapses, GlyT1b uptake should maintain [Gly]o beneath the saturation level of the NMDARs' glycine site. However, activation of glial AMPARs
by glutamate can lead to reverse transport conditions by depolarizing the astrocytes and raising [Na1]i locally, thus enhancing NMDAR
responses. High activity of neighboring glycinergic synapses could also increase [Gly]o at glutamatergic synapses, either by neurotransmitter
spillover or local reverse transport by GlyT1b following uptake of glycine in astrocyte processes close to the inhibitory synapses.
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the norepinephrine (NET) and the serotonin transporters has established uncoupled currents as a rule rather than
an exception. SERT, NET, GAT, DAT, and EAATs have(SERT), with the additional countertransport of one K1
or H1 ion in the latter case (reviewed by Rudnick, 1998). been reported to have substrate-evoked currents higher
than expected from their transport stoichiometry (re-GlyT1b has the same Na1 coupling (nNa 5 2) as the GABA
transporter GAT1 (Radian and Kanner, 1983; Mager et viewed by Sonders and Amara, 1996). However, two
remarks should be made. First, EAATs stand apart, asal., 1993; Lu and Hilgemann, 1999) and the dopamine
transporter (DAT) (Sonders et al., 1997). GlyT2a is the the main charge carrier of their uncoupled current is
Cl2, which is not a substrate for these transporters.first member of this family found to be coupled to 3
Na1. In the glutamate transporter family, studies using Second, the monoamine transporters face a smaller gra-
dient than the other transporters, as monoamine oxidasea similar methodology have reported the same 3 Na1
stoichiometry for the neuronal EAAT3 (Zerangue and keeps the intracellular concentrations of their substrates
in the micromolar range, while GAT, EAATs, GlyTs, andKavanaugh, 1996) and glial GLT1 (Levy et al., 1998)
transporters. However, despite their identical stoichio- the Na1/glucose cotransporter SGLT1 must face milli-
molar intracellular concentrations of their substratesmetries, these two glutamate transporters do not accu-
mulate similar intracellular/extracellular gradients in three orders of magnitude higher than those of mono-
amines.neurons and astrocytes in which glutamate is converted
to glutamine (reviewed by Kanai, 1997). This suggests Large charge-to-substrate flux ratios (3 to 200 charges
per substrate molecule) have been reported consistentlythat under physiological conditions, a transporter may
not reach equilibrium, as a balance is achieved between only for the monoamine transporters (reviewed by
Sonders and Amara, 1996; see also Galli et al., 1997;the size of the concentration gradient and the capacity
to maintain a high uptake rate. Under nonequilibrium Sonders et al., 1997). Contrasting with these results,
between 11 and 12 charges per glutamate were foundconditions, the greater driving force of GlyT2a may allow
it to compete effectively with GlyT1b for glycine released for EAAT1±EAAT3 in the absence of the uncoupled but
permeant anion Cl2 (Wadiche et al., 1995; Zerangue andat the synapse, despite the higher intracellular glycine
concentration. Kavanaugh, 1996), and the 22Na1-to-glucose flux ratio
of SGLT1 was found to be close to 12 (Mackenzie etEstimates of the glycine concentration ratios ([Gly]i/
[Gly]o) that GlyT1b and GlyT2a can maintain at equilib- al., 1998). GlyTs behave in the same way, with a tight
coupling between ionic and substrate fluxes. This isrium are z3 3 104 and 4 3 106, respectively, taking
[Na1]o 5 145 mM, [Na1]i 5 14 mM, [Cl2]o 5 120 mM, particularly true for GlyT1b, which exhibits no leak cur-
rent and has a strictly voltage-independent zT. The[Cl2]i 5 6 mM, and Vm 5 270 mV at 378C. Assuming
that intracellular glycine is 2 mM in astrocytes (in the charge coupling of GlyT2a appears less tight, but the
observed variations of zT are quite small (0.4 chargeshippocampus) (Berger et al., 1977) and 10 mM in gly-
cinergic neurons (Ottersen et al., 1990), these ratios are between 2120 mV and 0 mV) compared with other trans-
porters.compatible with an extracellular glycine concentration
below 0.1 mM, which is below saturation for NMDARs
(see Figure 7A). During ischemia, the accumulating Differences in Glycine Efflux
power of GlyT1b falls below 102 (assuming [Na1]o5 85 The thermodynamics of ion-coupled transport dictate
mM, [Na1]i 5 25 mM, [Cl2]o 5 120 mM, [Cl2]i 5 35 mM, that transporters work in a reverse mode when the mem-
and Vm 5 220 mV), which gives a minimal extracellular brane potential is more positive than is their equilibrium
concentration of 20 mM, close to what has been mea- potential. This inversion is well explained by cyclic alter-
sured (Baker et al., 1991). native access models (Lu and Hilgemann, 1999). Experi-
The difference in Na1 stoichiometry may be the basis mental evidence for non vesicular, calcium-independent
of most of the kinetic differences existing between the liberation of neurotransmitters has been reported for
steady-state and pre steady-state currents of the two GABA and glutamate transporters, and reverse uptake
glycine transporters. Thus, the voltage dependencies of is supposed to be a major release mechanism of GABA
the apparent Na1 and glycine affinities are higher for by retinal horizontal cells or for glutamate during ische-
GlyT2a than for GlyT1b. Differences in the characteristic mia (see review in Attwell et al., 1993).
transient currents observed in the absence of glycine Here, we show that GlyT2a has a kinetic constraint
but in the presence of Na1 also provide good support for reverse transport that limits glycine release. Such
for the binding of more Na1 ions to GlyT2a compared asymmetry in glycine fluxes may be essential to maintain
with GlyT1b (M. J. R. and S. S., unpublished data). a high amount of neurotransmitter inside the presynaptic
neurons during periods of electrical activity. However,
it has not been found for other neuronal transporters,Tight Coupling between Uptake
and Glycine-Evoked Current such as EAAT3 (Zerangue and Kavanaugh, 1996; Levy
et al., 1998) and GAT1 (Cammack et al., 1994; Lu andThe proportionality between glycine uptake and glycine-
evoked current over a wide range of potentials is of Hilgemann, 1999).
In our experimental conditions, GlyT reverse transportparticular importance for the analysis of the roles of
glycine transporters, as it means that glycine uptake was not detected unless intracellular glycine, Na1, or
Cl2 concentrations were elevated by microinjection orcan be monitored with the high time resolution of elec-
trophysiological techniques. The fact that this propor- prolonged uptake, producing outward currents that
could be blocked by transporter inhibitors, as describedtionality is that expected from the transport stoichi-
ometry contrasts with the recent electrophysiological in Figure 4. The difference in the voltage dependence of
GlyT2a inward and outward currents (Figure 5B) impliescharacterization of neurotransmitter transporters, which
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Electrophysiology and Data Analysisthat the forward and backward cycles are not governed
For most experiments, whole-cell currents were recorded as de-by the same kinetic steps, the nature of which has not
scribed in Supplisson and Bergman (1997). For uptake experiments,been precisely determined. Decreasing the external Na1
an open Teflon chamber was used, with a 3 M K-gluconate agar
or glycine concentrations did not enhance outward cur- bridge when required. The typical extracellular recording solution
rents, which suggests that external unbinding of ligands contained (in mM): NaCl, 100; CaCl2, 1.8; MgCl2, 1; and HEPES, 5
(pH 7.2, adjusted with KOH). In some experiments, choline andis not limiting. In contrast, internal binding of Na1 to
gluconate were substituted for Na1 and Cl2, respectively. Salts andthe transporter may be critical, since microinjection of
glycine were purchased from SIGMA. Data are given as mean 6glycine alone failed to activate outward current with
SEM.
GlyT2a despite the decrease of the reversal potential
(Figure 4B, top trace). This suggests that the third intra- Uptake Assays
cellular Na1 site has a lower affinity that limits reverse For glycine uptake, GlyT1b1 or GlyT2a1 oocytes were voltage
transport. clamped at different holding potentials (from 0 to 2120 mV), and
after application of 25 mM of U-14C glycine (specific activity of 103In contrast, the fact that GlyT1b exhibits no such limi-
mC/mmol, Amersham) for 45 to 120 s, oocytes were superfused fortation for reverse transport could be appropriate at both
30 to 60 s in control Ringer solution, then promptly washed in 1 mlexcitatory and inhibitory synapses, as illustrated in Fig-
of ice-cold choline-Cl Ringer for 10 s.
ure 7B. Near glycinergic terminals, the difference in the For chloride uptake, oocytes were held at 230 mV and superfused
energetic coupling of the two transporters may allow, with a 90 mM Na gluconate/10 mM NaCl solution until stabilization
by reverse transport from astrocytes, some leakage of of the membrane current (3 to 15 min), then superfused for 30 to
50 s with a 90 mM Na gluconate/10 mM Na 36Cl (specific activity ofglycine, which could subsequently be pumped by
z0.5 mC/mmol, Amersham) solution containing 1 mM glycine. TheGlyT2a into neurons. At glutamatergic synapses, GlyT1b
solution flow was stopped for 4 to 14 min; then oocytes were super-will lower ambient glycine to a submicromolar concen-
fused with the initial 10 mM NaCl solution for 1 to 2 min, promptly
tration, below saturation of the NMDAR high-affinity gly- washed three times in ice-cold choline-Cl Ringer solution, placed
cine site, thus reducing the activation of these receptors in solution containing 0.5 ml of 1% SDS, and counted on a Kontron
Betamatic.through their high-affinity glycine modulatory site (Supplis-
son and Bergman, 1997; Berger et al., 1998; Bergeron
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